Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
-95.0%
$0.01
$0.00
$0.22
$3K-0.3433,561 shs96,875 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$11.54
-1.4%
$12.60
$5.39
$19.22
$322.13M0.92256,092 shs238,044 shs
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$1.09
-0.5%
$1.01
$0.71
$1.61
$67.93M1.19149,168 shs89,131 shs
Profound Medical stock logo
PROF
Profound Medical
$6.02
+0.6%
$5.53
$3.90
$11.42
$180.75M0.4965,602 shs45,714 shs
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$243.34
-2.5%
$235.22
$178.26
$366.41
$1.88B1.11107,554 shs53,351 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00%+11.11%-13.04%-95.52%-93.33%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
0.00%+0.42%-14.93%+8.22%+117.83%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.00%-15.45%-1.89%+5.00%+14.42%
Profound Medical stock logo
PROF
Profound Medical
0.00%-0.25%+7.45%+27.61%-32.75%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
0.00%+5.03%+8.22%+30.45%-12.44%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
1.5192 of 5 stars
3.52.00.00.00.00.80.6
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
1.9467 of 5 stars
3.52.00.00.02.30.00.6
Profound Medical stock logo
PROF
Profound Medical
2.6529 of 5 stars
3.52.00.00.02.12.50.6
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
0.3167 of 5 stars
1.31.00.00.00.62.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00
N/AN/AN/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
3.00
Buy$25.00116.64% Upside
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
3.00
Buy$5.50406.91% Upside
Profound Medical stock logo
PROF
Profound Medical
3.00
Buy$11.5091.19% Upside
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
2.50
Moderate Buy$252.003.56% Upside

Current Analyst Ratings Breakdown

Latest PROF, CTSO, UFPT, AFIB, and CLPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.00
5/9/2025
Profound Medical stock logo
PROF
Profound Medical
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Moderate Buy
5/7/2025
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$252.00
5/2/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
4/23/2025
Profound Medical stock logo
PROF
Profound Medical
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $11.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.00N/AN/A($0.03) per share0.00
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$32.24M10.02N/AN/A$0.92 per share12.54
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$35.60M1.91N/AN/A$0.20 per share5.43
Profound Medical stock logo
PROF
Profound Medical
$10.68M16.92N/AN/A$2.01 per share2.99
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$504.42M3.72$10.45 per share23.28$44.66 per share5.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66MN/A0.00N/A-272.74%-311.64%-11.57%N/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$18.91M-$0.76N/AN/AN/A-64.51%-78.09%-51.33%8/6/2025 (Estimated)
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$20.72M-$0.28N/AN/AN/A-41.77%-105.04%-29.18%8/12/2025 (Estimated)
Profound Medical stock logo
PROF
Profound Medical
-$27.82M-$1.22N/AN/AN/A-269.35%-70.41%-57.22%8/6/2025 (Estimated)
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$58.98M$8.1729.78N/A11.59%21.27%12.24%7/30/2025 (Estimated)

Latest PROF, CTSO, UFPT, AFIB, and CLPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$2.29N/AN/AN/A$151.55 millionN/A
5/14/2025Q1 2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.08-$0.06+$0.02-$0.02$9.01 million$8.73 million
5/13/2025Q1 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.15-$0.22-$0.07-$0.22$8.21 million$8.49 million
5/8/2025Q1 2025
Profound Medical stock logo
PROF
Profound Medical
-$0.29-$0.36-$0.07-$0.36$4.78 million$2.62 million
5/6/2025Q1 2025
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$2.05$2.47+$0.42$2.21$139.93 million$148.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
N/AN/AN/AN/AN/A
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/A
1.85
1.57
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/A
3.53
2.57
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.98
2.61
2.30
Profound Medical stock logo
PROF
Profound Medical
0.09
11.31
10.03
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
0.47
2.58
1.45

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
Profound Medical stock logo
PROF
Profound Medical
47.86%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
87.28%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
5.21%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.97%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
6.60%
Profound Medical stock logo
PROF
Profound Medical
1.52%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
4.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
34029.78 million28.23 millionOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11027.99 million26.28 millionOptionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.61 million58.48 millionOptionable
Profound Medical stock logo
PROF
Profound Medical
15030.05 million29.60 millionOptionable
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
4,3357.71 million7.37 millionOptionable

Recent News About These Companies

UFPT UFP Technologies, Inc. - Seeking Alpha
What Makes UFP Technologies (UFPT) a Prospective Bet?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Acutus Medical stock logo

Acutus Medical NASDAQ:AFIB

$0.0001 0.00 (-95.00%)
As of 12:48 PM Eastern

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$11.54 -0.16 (-1.37%)
As of 02:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$1.08 -0.01 (-0.46%)
As of 02:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Profound Medical stock logo

Profound Medical NASDAQ:PROF

$6.02 +0.04 (+0.59%)
As of 02:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

UFP Technologies stock logo

UFP Technologies NASDAQ:UFPT

$243.34 -6.27 (-2.51%)
As of 02:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.